NX-1607 |
NX-1607 : Inhibitor of CBLB
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CBLB |
|
|
Inhibitor
1 uM, up to 10 uM
Selectivity
Potency Cellular
In Vitro
CBLB
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1038/s42003-023-05655-8
In Vivo Validations
Mouse
Dose: 1 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
0.31 h
Systemic clearance:
59.70 mL/min/Kg
Area Under the Curve::
281 h*ng/mL
Volume of Distribution at Steady-State:
1.55 L/Kg
DOI Reference: 10.1016/j.ejmech.2025.117488
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
2.68 h
Cmax:
629 ng/mL
Tmax:
0.33 h
Area Under the Curve::
690 h*ng/mL
Bioavailability:
24.6%
DOI Reference: 10.1038/s42003-023-05655-8
Chemical Information
| Molecular Formula | C30H34F3N5O |
| SMILEs | C[C@H]1CCCN(Cc2cc3c(c(C(F)(F)F)c2)CN(c2cccc([C@]4(c5nncn5C)C[C@@H](C)C4)c2)C3=O)C1 |
| InChI | InChI=1S/C30H34F3N5O/c1-19-6-5-9-37(15-19)16-21-10-24-25(26(11-21)30(31,32)33)17-38(27(24)39)23-8-4-7-22(12-23)29(13-20(2)14-29)28-35-34-18-36(28)3/h4,7-8,10-12,18-20H,5-6,9,13-17H2,1-3H3/t19-,20-,29+/m0/s1 |
| Molecular weight | 537.27 Da |
| AlogP | 5.942200000000007 |
| HBond acceptors | 6 |
| HBond donors | -- |
| Atoms | 73 |